PetIQ (PETQ)
(Delayed Data from NSDQ)
$21.78 USD
-0.16 (-0.73%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $21.78 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
B Value F Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PETQ 21.78 -0.16(-0.73%)
Will PETQ be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for PETQ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PETQ
Wall Street Analysts See a 40.44% Upside in PetIQ (PETQ): Can the Stock Really Move This High?
Are Investors Undervaluing PetIQ (PETQ) Right Now?
PETQ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Has Entera Bio (ENTX) Outpaced Other Medical Stocks This Year?
Despite Fast-paced Momentum, PetIQ (PETQ) Is Still a Bargain Stock
Wall Street Analysts See a 45.22% Upside in PetIQ (PETQ): Can the Stock Really Move This High?
Other News for PETQ
PetIQ, Inc. to Participate in the Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference
PetIQ, Inc. (PETQ) Q1 2024 Earnings Call Transcript
PetIQ, Inc. 2024 Q1 - Results - Earnings Call Presentation
PetIQ Inc (PETQ) Surpasses Q1 Revenue and Earnings Expectations, Raises 2024 Outlook
Analysts Are Bullish on These Healthcare Stocks: Coherus Biosciences (CHRS), Petiq (PETQ)